Follow
Saranrat Wittayanukorn
Saranrat Wittayanukorn
Scientist, Office of Surveillance and Epidemiology, CDER/FDA
Verified email at fda.hhs.gov - Homepage
Title
Cited by
Cited by
Year
Prevalence of depressive symptoms and predictors of treatment among US adults from 2005 to 2010
S Wittayanukorn, J Qian, RA Hansen
General hospital psychiatry 36 (3), 330-336, 2014
1052014
Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan
S Wittayanukorn, SC Westrick, RA Hansen, N Billor, K Braxton-Lloyd, ...
Journal of Managed Care Pharmacy 19 (5), 385-395, 2013
862013
Prevention of Trastuzumab and Anthracycline-induced Cardiotoxicity Using Angiotensin-converting Enzyme Inhibitors or β-blockers in Older Adults With Breast Cancer
S Wittayanukorn, J Qian, SC Westrick, B Billor, B Johnson, RA Hansen
American Journal of Clinical Oncology, 2017
532017
Interventions for adherence with oral chemotherapy in hematological malignancies: a systematic review
J Kavookjian, S Wittayanukorn
Research in Social and Administrative Pharmacy 11 (3), 303-314, 2015
332015
Cardiotoxicity in targeted therapy for breast cancer: A study of the FDA adverse event reporting system (FAERS)
S Wittayanukorn, J Qian, BS Johnson, RA Hansen
Journal of Oncology Pharmacy Practice 23 (2), 93-102, 2017
322017
Predictive analysis of first abbreviated new drug application submission for new chemical entities based on machine learning methodology
M Hu, A Babiskin, S Wittayanukorn, A Schick, M Rosenberg, X Gong, ...
Clinical Pharmacology & Therapeutics 106 (1), 174-181, 2019
132019
Treatment patterns among breast cancer patients in the United States using two national surveys on visits to physicians' offices and hospital outpatient departments
S Wittayanukorn, J Qian, SC Westrick, N Billor, B Johnson, RA Hansen
Research in Social and Administrative Pharmacy 11 (5), 708-720, 2015
92015
Factors that have an impact on abbreviated new drug application (ANDA) submissions
S Wittayanukorn, M Rosenberg, A Schick, M Hu, Z Wang, A Babiskin, ...
Therapeutic Innovation & Regulatory Science 54, 1372-1381, 2020
72020
Patterns of psychiatric emergency department utilization among community-dwelling Medicare beneficiaries under 65.
J Qian, S Wittayanukorn, RA Hansen
Psychological services 14 (3), 387, 2017
62017
Comparative outcomes of treatment initiation with brand vs. generic warfarin in older patients
RJ Desai, C Gopalakrishnan, S Dejene, AS Sarpatwari, R Levin, ...
Clinical Pharmacology & Therapeutics 107 (6), 1334-1342, 2020
5*2020
Factors associated with psychotropic prescriptions, psychiatric hospitalization, and spending among Medicare beneficiaries under 65
J Qian, S Wittayanukorn, G McGuffey, R Hansen
Disability and Health Journal 8 (3), 424-433, 2015
42015
What factors may impact the likelihood of first abbreviated new drug application (ANDA) submission for a reference product?
S Wittayanukorn, M Rosenberg, A Schick, M Hu, Z Wang, A Babiskin, ...
Value in Health 21, S116, 2018
32018
Data-driven automated classification algorithms for acute health conditions: Applying PheNorm to COVID-19 disease
JC Smith, BD Williamson, DJ Cronkite, D Park, JM Whitaker, ...
Journal of the American Medical Informatics Association 31 (3), 574-582, 2024
12024
Risk of Cardiotoxicity and All-Cause Mortality in Breast Cancer Patients after Adjuvant Chemotherapy or Hormonal Therapy
S Wittayanukorn, J Qian, SC Westrick, N Billor, B Johnson, RA Hansen
Value in Health 18 (3), A190, 2015
12015
Patterns of Psychotropic prescription Utilization among disabled Medicare Beneficiaries Under 65
J Qian, S Wittayanukorn, RA Hansen
Value in Health 18 (3), A125, 2015
12015
US emergency department visits for prescription opioid adverse events in older adults, 2016 to 2018
C Greene, R Radin, S Wittayanukorn, JG Naples, CL Collins, J Staffa
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 389-390, 2022
2022
Data-driven approaches to improve phenotype sensitivity using EHR data
S Toh, D Carrell, JC Smith, D Park, J Whitaker, MF McLemore, ...
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 549-549, 2022
2022
Benzodiazepine use, nonmedical use, and overdose in the US
S Wittayanukorn, A Seitz, D Bak, R Radin, S Karami, N Sadiq, R Gill, ...
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 155-156, 2021
2021
Prescribing and non-medical use of tramadol and other opioid analgesics: US, 2009-2018
S Wittayanukorn, I Ibrahim, R Radin, S Karami, R Gill, G Chai, J McAninch
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 485-486, 2020
2020
PATTERNS OF BIOEQUIVALENCE RECOMMENDATIONS AND TRENDS OF ABBREVIATED NEW DRUG APPLICATIONS APPROVAL OVER TIME
S Wittayanukorn, A Babiskin, S Dutcher, X Pu, M Hu, L Zhao, ...
Value in Health 19 (3), A286, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20